activebuyx

Gaetano @crux_capital_ Nov 3, 2025 What does $POET actually sell? We’ve covered why $POET's technology is a big deal ...

Gaetano (@crux_capital_) frames POET Technologies ($POET) as an AI/optics thematic opportunity. The thread highlights the company’s potential importance for AI hardware but emphasizes that investors should focus on what POET actually sells, its product lineup, and its go-to-market strategy. Actionable detail is limited in the excerpt; key investable issues are product definition, customer adoption, and manufacturing execution.

Confidence
35 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

$POET is the primary ticker discussed; the broader thematic commentary also references optical-sector names as comparators in prior posts but they are not the focus of this specific excerpt.

POETbuyopen
Confidence: 35 / 100Start: $12.15Latest: $8.76Return: -27.90%

Only explicit cashtag mentioned; claim is directional (AI relevance) but lacks details on what is sold, adoption, or timing in the provided text.

Source proof

Source proof: Strong source proof | 3 extracted claims | 1 directional asset | 1 supporting author | headline-like title review

Content is sourced from a single, truncated social post by Gaetano (@crux_capital_), dated Nov 3, 2025, which asserts $POET’s technology is significant for AI but cuts off before enumerating product details. Related posts from the same author provide additional context (a Nov 5 deep-dive referencing ~$300M and first production orders) but concrete product, contract, or timing details are absent in the provided excerpts.

Gaetano @crux_capital_ 7m Update post earnings $MXL Market cap: ~$6.5B Next-quarter guide: ~$215M (+27.4% QoQ, +70.0%...
crux_capital_ · Jul 24, 2026, 7:38 PM EDT

Post-earnings update on $MXL with specific forward revenue/margin estimates and a technical level (~$68–$70) described as a “critical zone.” Prior post (Jul 21) previewed earnings and projected similar but lower near-term guide and margins. Actionable primarily for a $MXL long thesis tied to guide strength and sustained high growth over the next 4 quarters; limited broader market read-through.

View source
Gaetano @crux_capital_ 37m $NOK Bank of America raised its price target on Nokia to $18.50 from $18 while reiterating...
crux_capital_ · Jul 24, 2026, 4:02 PM EDT

Speaker highlights Bank of America raising its price target on Nokia ($NOK) to $18.50 (from $18) reiterating Buy, and argues Nokia’s earnings were stronger than the stock reaction. Notes segment growth (Optical +20%, IP +16%) and that prior design wins are converting, while acknowledging “macro is heavy.”

View source
Gaetano @crux_capital_ 1h One bit that is really interesting to me $IQE Is their potential work around for China's pe...
crux_capital_ · Jul 24, 2026, 6:08 AM EDT

Speaker highlights a potentially investable, but low-clarity supply-chain/regulatory workaround: IQE may be able to partially work around China permit issues affecting AXTI. Also notes they have “reconsidered” SIVE and IQE over recent months, implying a shifting (more positive) view on IQE but without explicit positioning or price targets.

View source
Gaetano @crux_capital_ 6h $SIVE Isn't the only company I have reconsidered... I have spent a lot of time thinking abo...
crux_capital_ · Jul 23, 2026, 10:00 PM EDT

Post indicates the author is reconsidering views on $SIVE/$SIVEF and $IQE after new developments over recent months. The only concrete investable content is a shift in stance and specific prior concerns on $SIVE around ramp timing and competitive landscape in CPO; details are truncated (“Show more”), limiting actionability.

View source
Gaetano @crux_capital_ 8h Another amazing quarter $MXL > Q2 revenue hit $168.8M, up 55% YoY and 23% sequentially > In...
crux_capital_ · Jul 23, 2026, 7:36 PM EDT

Post highlights strong reported and guided fundamentals for MaxLinear (MXL): Q2 revenue growth, infrastructure segment acceleration, margin expansion, and a higher Q3 revenue guide. Also includes author’s forward 4-quarter revenue and margin estimates and an implied bullish setup into/around earnings.

View source
Pinned Gaetano @crux_capital_ May 27 I believe Physical AI Is the Next Supercycle It is much much more than humanoids...
crux_capital_ · May 27, 2026, 5:00 AM EDT

Speaker claims “Physical AI” will be the next supercycle (beyond humanoids) with multi-layered investment opportunities, but provides no specific public tickers tied to Physical AI in the excerpt. Separately, speaker cites an “optical super cycle” as having delivered strong returns and explicitly lists optical-related tickers ($LITE $COHR $CIEN $AAOI $AXTI $SIVE), implying bullish framing and a desire to find the next analogous theme. Most content is thematic and retrospective; only the optical tickers are directly investable from the text.

View source
Gaetano @crux_capital_ Nov 5, 2025 My new deep-dive on POET Technologies $POET is live. With $300M and its first prod...
crux_capital_ · Nov 5, 2025, 6:45 PM EST

Post promotes a new deep-dive on POET Technologies ($POET), framing the company at an inflection point due to ~$300M and first production orders. Key stated risk has shifted from financing to manufacturing execution amid heavy competition. Limited actionable specifics (no timing, volumes, named partners, or guidance), but does create an investable implication around production ramp/fulfillment risk-reward.

View source
Gaetano @crux_capital_ Nov 3, 2025 What does $POET actually sell? We’ve covered why $POET's technology is a big deal ...
crux_capital_ · Nov 3, 2025, 3:46 PM EST

Single, truncated social post discussing POET Technologies ($POET). The speaker frames $POET’s technology as “a big deal for AI” and suggests investors should focus on what the company sells and its product lineup/strategy (mentions “Optical…” but the text is cut off). Actionability is limited because there are no concrete product details, contracts, catalysts, numbers, or timing in the provided excerpt.

View source

Supporting authors

Single author: Gaetano (@crux_capital_). No additional authors or third-party confirmations are included in the excerpt.

Unlock full thesis monitoring

For investors: focus due diligence on POET’s product definitions, customer engagements, manufacturing ramp capability, and any public disclosures (orders, partners, production milestones). Consider reading Gaetano’s Nov 5 deep-dive for broader context, but note the excerpts here lack verifiable details on volumes, timing, or counterparties.

Gaetano @crux_capital_ Nov 3, 2025 What does $POET actually sell? We’ve covered why $POET's technology is a big deal ... | AI Frontrunner